SCMC Trial on KHE With KMP (V.2020)

Inclusion Criteria: * Kaposiform Hemangioendotheliomas with Kasabach-Merritt Phenomenon * 0 - 12 years of age at the time of study entry * Male or female * Consent of parents (or the person having parental authority in families) * Signed and dated written informed consent Exclusion Criteria: * with hematological diseases * with other solid tumors * with hypertension, diabetes, adrenal insufficiency, neurological diseases, liver and kidney * dysfunction, and cardiopulmonary insufficiency * with tuberculosis,cytomegalovirus and Epstein-Barr virus infection before the treatment